 | Up a level |
Bounaix, Laura; Schröder, Verena; Fontana, Pierre; Casini, Alessandro (2024). Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature. Research and practice in thrombosis and haemostasis, 8(2) Wiley 10.1016/j.rpth.2024.102371
Golomingi, Murielle; Kohler, Jessie; Lamers, Christina; Pouw, Richard B; Ricklin, Daniel; Dobó, József; Gál, Péter; Pál, Gábor; Kiss, Bence; Dopler, Arthur; Schmidt, Christoph Q; Hardy, Elaissa Trybus; Lam, Wilbur; Schroeder, Verena (2023). Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels. Frontiers in immunology, 14(1226832), p. 1226832. Frontiers Research Foundation 10.3389/fimmu.2023.1226832
Li, Bojun; Bechtler, Clément; Jenny, Lorenz; Ricklin, Daniel; Schroeder, Verena (2022). Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners. Research and practice in thrombosis and haemostasis, 6(5), e12766. Wiley 10.1002/rth2.12766
Mutch, Nicola J; Walters, Sam; Gardiner, Elizabeth E; McCarty, Owen J T; De Meyer, Simon F; Schroeder, Verena; Meijers, Joost C M (2022). Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH. Journal of thrombosis and haemostasis, 20(6), pp. 1496-1506. Wiley-Blackwell 10.1111/jth.15718
Raut, Sanj; Katona, Éva; Riches-Duit, Andrew; Coxon, Carmen; Muszbek, László; Schroeder, Verena; Rigsby, Peter (2022). An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): Communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen. Journal of thrombosis and haemostasis, 20(2), pp. 525-531. Wiley-Blackwell 10.1111/jth.15596
Golomingi, Murielle; Kohler, Jessie; Jenny, Lorenz; Hardy, Elaissa T; Dobó, József; Gál, Péter; Pál, Gábor; Kiss, Bence; Lam, Wilbur A; Schroeder, Verena (2022). Complement lectin pathway components MBL and MASP-1 promote haemostasis upon vessel injury in a microvascular bleeding model. Frontiers in immunology, 13, p. 948190. Frontiers Research Foundation 10.3389/fimmu.2022.948190
Sánchez van Kammen, Mayte; Heldner, Mirjam R.; Brodard, Justine; Scutelnic, Adrian; Silvis, Suzanne; Schroeder, Verena; Kremer Hovinga, Johanna A.; Middeldorp, Saskia; Levi, Marcel; Hiltunen, Sini; Lindgren, Erik; Mansour, Maryam; Arauz, Antonio; Barboza, Miguel A.; Zuurbier, Susanna M.; Aguiar de Sousa, Diana; Ferro, Jose M.; Fischer, Urs; Field, Thalia S.; Jood, Katarina; ... (2021). Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA : the journal of the American Medical Association, 326(4), pp. 332-338. American Medical Association 10.1001/jama.2021.9889
Schroeder, Verena (2020). Laboratory Assessment of Coagulation Factor XIII. Hämostaseologie, 40(4), pp. 467-471. Thieme 10.1055/a-1181-0327
Heldner, Mirjam R.; Zuurbier, Susanna M.; Li, Bojun; von Martial, Rascha; Meijers, Joost C. M.; Zimmermann, Rebekka; Volbers, Bastian; Jung, Simon; El-Koussy, Marwan; Fischer, Urs; Kohler, Hans P.; Schroeder, Verena; Coutinho, Jonathan M.; Arnold, Marcel (2020). Prediction of Cerebral Venous Thrombosis with a new clinical score and D-dimer levels. Neurology, 95(7), e898-e909. American Academy of Neurology 10.1212/WNL.0000000000009998
Li, Bojun; Kohler, Hans P.; Schroeder, Verena (2020). Identification of amino acid residues that are crucial for FXIII-A intersubunit interactions and stability. Blood, 135(2), pp. 145-152. American Society of Hematology 10.1182/blood.2019002127
Jenny, Lorenz; Melmer, Andreas; Laimer, Markus; Hardy, Elaissa T; Lam, Wilbur A; Schroeder, Verena (2020). Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study. Diabetes & vascular disease research, 17(1), p. 1479164120903044. Sage 10.1177/1479164120903044
Orosz, Zsuzsanna Z; Bárdos, Helga; Shemirani, Amir H; Beke Debreceni, Ildikó; Lassila, Riitta; Riikonen, Antti S; Kremer Hovinga, Johanna A.; Seiler, Theo G.; van Dorland, Hendrika A.; Schroeder, Verena; Boda, Zoltán; Nemes, László; Früh Epstein, Beatrice; Nagy, Bence; Facskó, Andrea; Kappelmayer, János; Muszbek, László (2019). Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes. International journal of molecular sciences, 20(23) MDPI 10.3390/ijms20235963
Jenny, Lorenz; Noser, Danilo; Larsen, Julie Brogaard; Dobó, József; Gál, Péter; Pál, Gábor; Schroeder, Verena (2019). MASP-1 of the complement system alters fibrinolytic behaviour of blood clots. Molecular immunology, 114, pp. 1-9. Elsevier 10.1016/j.molimm.2019.07.005
Ajjan, Ramzi A; Schroeder, Verena (2019). Role of complement in diabetes. Molecular immunology, 114, pp. 270-277. Elsevier 10.1016/j.molimm.2019.07.031
Li, Bojun; Heldner, Mirjam R.; Arnold, Marcel; Coutinho, Jonathan M; Zuurbier, Susanna M; Meijers, Joost C M; Kohler, Hans P; Schroeder, Verena (2019). Coagulation Factor XIII in Cerebral Venous Thrombosis. TH open, 3(3), e227-e229. Thieme 10.1055/s-0039-1693487
Engelberger, Rolf P; Schroeder, Verena; Nagler, Michael; Prince, Raja; Périard, Daniel; Hayoz, Daniel; Kucher, Nils (2019). Enhanced Thrombolysis by Ultrasound-Assisted Catheter-Directed Thrombolysis and Microbubbles in an In Vitro Model of Iliofemoral Deep Vein Thrombosis. Thrombosis and haemostasis, 119(7), pp. 1094-1101. Thieme 10.1055/s-0039-1688973
Li, Bojun; Billur, Ramya; Maurer, Muriel C; Kohler, Hans-Peter; Raddatz Müller, Pascale; Alberio, Lorenzo; Schroeder, Verena (2018). Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation. Thrombosis and haemostasis, 118(12), pp. 2037-2045. Thieme 10.1055/s-0038-1675600
Li, Bojun; Borhany, Munira; Abid, Madiha; Kohler, Hans-Peter; Schroeder, Verena (2018). Identification of a novel nonsense mutation leading to congenital factor XIII deficiency. Thrombosis research, 165, pp. 83-85. Elsevier 10.1016/j.thromres.2018.03.019
Jenny, Lorenz; Dobó, József; Gál, Péter; Pál, Gábor; Lam, Wilbur A; Schroeder, Verena (2018). MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model. PLoS ONE, 13(1), e0191292. Public Library of Science 10.1371/journal.pone.0191292
Kool, Remi O; Kohler, Hans P.; Coutinho, Jonathan M; Levi, Marcel; Coppens, Michiel; Meijers, Joost C M; Schroeder, Verena (2017). Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosis. Thrombosis research, 159, pp. 96-99. Elsevier 10.1016/j.thromres.2017.10.009
Schroeder, Verena; Kohler, Hans P (2016). Factor XIII: Structure and Function. Seminars in thrombosis and hemostasis, 42(4), pp. 422-428. Thieme Medical Publishers 10.1055/s-0036-1571341
Handrková, Helena; Schroeder, Verena; Kohler, H P (2015). The activation peptide of coagulation factor XIII is vital for its expression and stability. Journal of thrombosis and haemostasis, 13(8), pp. 1449-1458. Wiley-Blackwell 10.1111/jth.13035
Jenny, Lorenz; Dobó, József; Gál, Péter; Schroeder, Verena (2015). MASP-1 of the complement system promotes clotting via prothrombin activation. Molecular immunology, 65(2), pp. 398-405. Elsevier 10.1016/j.molimm.2015.02.014
Handrková, Helena; Borhany, M; Schroeder, Verena; Fatima, N; Hussain, A; Shamsi, T; Kohler, H P (2015). Identification of two novel missense mutations causing severe factor XIII deficiency. Haemophilia, 21(3), e253-e256. Blackwell Science 10.1111/hae.12663
Jenny, Lorenz; Ajjan, Ramzi; King, Rhodri; Thiel, Steffen; Schroeder, Verena (2015). Plasma Levels of MASP-1 and MASP-2 are Elevated in Type 1 Diabetes and Correlate with Glycaemic Control. Clinical and experimental immunology, 180(2), pp. 227-232. Blackwell Scientific Publications 10.1111/cei.12574
Schroeder, Verena; Handrková, Helena; Dodt, Johannes; Kohler, Hans-Peter (2015). Free factor XIII activation peptide affects factor XIII function. British journal of haematology, 168(5), pp. 757-759. Wiley-Blackwell 10.1111/bjh.13144
Jenny, Lorenz; Dobó, József; Gál, Péter; Schroeder, Verena (2015). MASP-1 Induced Clotting--The First Model of Prothrombin Activation by MASP-1. PLoS ONE, 10(12), e0144633. Public Library of Science 10.1371/journal.pone.0144633
Schroeder, Verena; Carter, A M; Dunne, J; Mansfield, M W; Grant, P J (2010). Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes. Journal of thrombosis and haemostasis, 8(9), pp. 2080-2082. Wiley-Blackwell 10.1111/j.1538-7836.2010.03966.x
Schroeder, Verena; Kohler, H.-P. (2010). Faktor XIII. In: Pötsch, Bernd; Madlener, Katharina (eds.) Hämostaseologie. Grundlagen, Diagnostik und Therapie (pp. 219-225). Springer
Polkinghorne, Victoria R; Standeven, Kristina F; Schroeder, Verena; Carter, Angela M (2009). Role of proteomic technologies in understanding risk of arterial thrombosis. Expert review of proteomics, 6(5), pp. 539-550. Taylor & Francis 10.1586/epr.09.75
Castaman, G; Giacomelli, S H; Ivaskevicius, V; Schroeder, Verena; Kohler, Hans-Peter; Dragani, A; Biasioli, C; Oldenburg, J; Madeo, D; Rodeghiero, F (2008). Molecular characterization of five Italian families with inherited severe factor XIII deficiency. Haemophilia, 14(1), pp. 96-102. Wiley 10.1111/j.1365-2516.2007.01603.x
Schroeder, Verena; Durrer, Dominik; Meili, Esther; Schubiger, Gregor; Kohler, Hans Peter (2007). Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005. Swiss medical weekly, 137(19-20), pp. 272-278. EMH Media 10.4414/smw.2007.11756
Schmid, Jean-Paul; Schroeder, Verena (2005). Nicorandil – Review of Pharmacological Properties and Clinical Applications. Heart drug, 5(4), pp. 220-229. Karger 10.1159/000089603
Kucher, Nils; Schroeder, Verena; Kohler, Hans P (2003). Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness. Thrombosis and haemostasis, 90(3), pp. 434-438. Schattauer 10.1160/TH03-07-0031
Chatterjee, T; Schroeder, Verena; Windecker, S; Meier, B; Kohler, H P (2003). Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease. Journal of thrombosis and haemostasis, 1(4), pp. 861-863. Blackwell 10.1046/j.1538-7836.2003.t01-8-00115.x
Schroeder, Verena; Kucher, N; Kohler, H P (2003). Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism. Journal of thrombosis and haemostasis, 1(3), pp. 492-493. Blackwell 10.1046/j.1538-7836.2003.00112.x
Schroeder, Verena; Kohler, Hans P (2003). Factor XIII activation by thrombin depends on FXIIIVal34Leu genotype. Blood, 101(1), pp. 371-372. American Society of Hematology 10.1182/blood-2002-08-2427
Schroeder, Verena; Chatterjee, Tushar; Mehta, Haresh; Windecker, Stephan; Pham, Trinh; Devantay, Nicolas; Meier, Bernhard; Kohler, Hans P (2002). Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. Thrombosis and haemostasis, 88(6), pp. 1020-1025. Schattauer
Ferrari, Paolo; Schroeder, Verena; Anderson, Suzanne; Kocovic, Leonardo; Vogt, Bruno; Schiesser, Daniela; Marti, Hans-Peter; Ganz, Reinhold; Frey, Felix J; Kohler, Hans P (2002). Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation, 74(8), pp. 1147-1152. Lippincott Williams & Wilkins 10.1097/01.TP.0000035848.73883.1B
Wilmer, M.; Schroeder, Verena; Kohler, H. P. (2002). Methoden zur Bestimmung des Faktors XIII/XIIIa. Hämostaseologie, 22(01), pp. 18-28. Schattauer 10.1055/s-0037-1622004
Kohler, H.P.; Schroeder, Verena (2002). Die Rolle von Faktor XIII bei kardio- und zerebrovaskulären Erkrankungen. Hämostaseologie, 22(01), pp. 39-44. Schattauer 10.1055/s-0037-1622007
Schroeder, Verena; Chatterjee, T; Kohler, H P (2001). Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thrombosis research, 104(6), pp. 467-474. Elsevier 10.1016/s0049-3848(01)00395-4
Schroeder, Verena; Kohler, H P (2000). Effect of factor XIII Val34Leu on alpha2-antiplasmin incorporation into fibrin. Thrombosis and haemostasis, 84(6), pp. 1128-1130. Schattauer
